E-LIB Suche - Ergebnisse für: Betts, Keith A.

1

Real-World Patterns and Economic Burden Associated With Tre..:

Lee, Scott D ; Betts, Keith A ; Xiaoyan Du, Ella...
Crohn's & Colitis 360. 6 (2024) 2 - p. , 2024

Link: https://doi.org/10.1093/..

2

Real-world safety of first-line immuno-oncology combination..:

Betts, Keith A ; Gao, Sophie ; Ray, Saurabh.
Future Oncology. 20 (2024) 13 - p. 851-862 , 2024

Link: https://doi.org/10.2217/..

3

Safety of Upadacitinib in Immune-Mediated Inflammatory Dise..:

Mysler, Eduardo ; Burmester, Gerd R. ; Saffore, Christopher D....
Advances in Therapy. 41 (2024) 2 - p. 567-597 , 2024

Link: https://doi.org/10.1007/..

4

Clinical outcomes of adjuvant nivolumab in resected stage I..:

Moser, Justin C. ; Bhatia, Shailender ; Amin, Asim...
Cancer Immunology, Immunotherapy. 73 (2024) 7 - p. , 2024

Link: https://doi.org/10.1007/..

5

Tolvaptan and Number Needed to Harm in Autosomal Dominant P..:

Betts, Keith A. ; Nunna, Sasikiran ; Kumar, Retesh..
Kidney Medicine. 6 (2024) 4 - p. 100802 , 2024

Link: https://doi.org/10.1016/..

6

Su1147 ECONOMIC BURDEN OF SUBOPTIMAL TREATMENT WITH CONVENT..:

Horst, Sara N. ; Suryavanshi, Manasi ; Betts, Keith...
Gastroenterology. 164 (2023) 6 - p. S-546 , 2023

Link: https://doi.org/10.1016/..

7

Comparative Efficacy of Venetoclax-Based Combination Therap..:

Li, Xue ; Suh, Hae Sun ; Lachaine, Jean...
Value in Health. 26 (2023) 12 - p. 1689-1696 , 2023

Link: https://doi.org/10.1016/..

8

Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroeso..:

Sugarman, Ryan ; Betts, Keith A. ; Nie, Xiaoyu..
Clinical Therapeutics. 45 (2023) 11 - p. 1155-1158 , 2023

Link: https://doi.org/10.1016/..

9

Grade 3/4 Adverse Event Costs of Immuno-oncology Combinatio..:

McGregor, Bradley ; Geynisman, Daniel M ; Burotto, Mauricio...
The Oncologist. 28 (2023) 1 - p. 72-79 , 2023

Link: https://doi.org/10.1093/..

10

A Matching-adjusted Indirect Comparison of Nivolumab Plus C..:

McGregor, Bradley ; Geynisman, Daniel M. ; Burotto, Mauricio...
European Urology Oncology. 6 (2023) 3 - p. 339-348 , 2023

Link: https://doi.org/10.1016/..

11

Impact of benralizumab on asthma exacerbation-related medic..:

Chung, Yen ; Maselli, Diego J. ; Mu, Fan...
Journal of Medical Economics. 26 (2023) 1 - p. 954-962 , 2023

Link: https://doi.org/10.1080/..

12

Development of a triage algorithm for mild cognitive impair..:

Li, Gang ; Batrla, Richard ; Betts, Keith A....
Alzheimer's & Dementia. 19 (2023) S23 - p. , 2023

Link: https://doi.org/10.1002/..

13

Real-World Effectiveness Study of Benralizumab for Severe E..:

Carstens, Donna ; Maselli, Diego J. ; Mu, Fan...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 7 - p. 2150-2161.e4 , 2023

Link: https://doi.org/10.1016/..

14

A Response to: Letter to the Editor Regarding Long-Term Ben..:

Armstrong, April W. ; Soliman, Ahmed M. ; Betts, Keith A....
Dermatology and Therapy. 12 (2022) 12 - p. 2867-2870 , 2022

Link: https://doi.org/10.1007/..

15

The Economic Burden of Eosinophilic Gastritis and Eosinophi..:

Woolley, Michael ; Cook, Erin E. ; Mu, Fan...
Advances in Therapy. 39 (2022) 8 - p. 3547-3559 , 2022

Link: https://doi.org/10.1007/..